INFLUENCE OF DIAGNOSTIC RADIOIODINES ON THE UPTAKE OF ABLATIVE DOSE OF I-131
INFLUENCE OF DIAGNOSTIC RADIOIODINES ON THE UPTAKE OF ABLATIVE DOSE OF I-131
复制标题
DOI:
10.1089/thy.1994.4.49
复制
发表时间:
1994-03-01
期刊:
影响因子:
6.6
通讯作者:
MANATUNGA, A
中科院分区:
文献类型:
--
作者:
PARK, HM;PERKINS, OW;MANATUNGA, A
The uptakes of thyroablative doses of I-131 by postoperative thyroid remnants and/or thyroid carcinoma metastases following diagnostic surveys with I-131 or I-123 were retrospectively compared by visual inspection. Only those patients with a diagnostic scan demonstrating functioning tissue, remnant, and/or metastasis, following thyroidectomy for differentiated thyroid carcinoma, were evaluated. The I-131 survey group (n = 26) had received a diagnostic dose of 3 to 10 mCi of I-131. The I-123 group (n = 14) had received the usual diagnostic dose of 300 mu Ci of I-123. Th,,ge, sex, and tumor type in the two groups were not statistically different. The uptake of the ensuing thyroablative dose of I-131 appeared, by visual inspection, to be impaired in 20 of 26 patients in the I-131 group and in none of the 14 patients in the I-123 group (p < 0.00003). In the I-131 group there was suggestion of a dose-response, that is, the higher the administered activity of I-131 for the diagnostic scan, the more reduced was the subsequent apparent uptake of the thyroablative dose (p = 0.0007). Thyroid remnants or cervical lymph node metastases appeared to be affected more frequently than were the distant (pulmonary or skeletal) metastases (p = 0.004). This study suggests that iodine uptake function may be suppressed by the absorbed radiation from the 3 to 10 mCi ''diagnostic'' scanning dose of I-131. In this regard, I-123 may be better initial diagnostic agent to be used prior to radioablation therapy.